FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Dal Poggetto John
 2. Date of Event Requiring Statement (Month/Day/Year)
09/27/2019		 3. Issuer Name and Ticker or Trading Symbol
Sonoma Pharmaceuticals, Inc. [SNOA]
(Last)
(First)
(Middle)
1129 N. MCDOWELL BLVD		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Financial Officer
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

PETALUMA, CA 94954		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, $0.0001 par value per share 115
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) 02/25/2010 02/25/2020 Common Stock 223 $ 576.45 D  
Stock Option (right to buy) 05/17/2011 05/17/2021 Common Stock 286 $ 595.35 D  
Stock Option (right to buy) 08/24/2015 08/24/2022 Common Stock 96 $ 292.95 D  
Stock Option (right to buy) 09/19/2016 09/19/2023 Common Stock 238 $ 133.65 D  
Stock Option (right to buy) 03/04/2017 03/04/2024 Common Stock 1,648 $ 175.5 D  
Stock Option (right to buy) 08/21/2015 08/21/2025 Common Stock 1,251 $ 52.2 D  
Stock Option (right to buy)   (1) 08/21/2025 Common Stock 420 $ 52.2 D  
Stock Option (right to buy)   (2) 04/11/2027 Common Stock 1,334 $ 61.92 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Dal Poggetto John
1129 N. MCDOWELL BLVD
PETALUMA, CA 94954		       Chief Financial Officer  

Signatures

/s/ John Dal Poggetto 10/15/2019
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Options vest upon the achievement of certain goals.
(2) Options vest in three equal tranches annually on the grant date anniversary, beginning on April 11, 2018 and becoming fully vested on April 11, 2020.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.